Transgene Biotek reports consolidated net loss of Rs 2.61 crore in the March 2021 quarter

Sales reported at Rs 0.01 crore

Net Loss of Transgene Biotek reported to Rs 2.61 crore in the quarter ended March 2021 as against net loss of Rs 2.79 crore during the previous quarter ended March 2020. Sales reported to Rs 0.01 crore in the quarter ended March 2021. There were no Sales reported during the previous quarter ended March 2020.

For the full year,net loss reported to Rs 10.43 crore in the year ended March 2021 as against net loss of Rs 10.96 crore during the previous year ended March 2020. Sales reported to Rs 0.17 crore in the year ended March 2021. There were no Sales reported during the previous year ended March 2020.

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales0.010 0 0.170 0 OPM %-1900.000 --311.760 - PBDT-0.13-0.31 58 -0.53-1.07 50 PBT-2.61-2.79 6 -10.43-10.96 5 NP-2.61-2.79 6 -10.43-10.96 5

Powered by Capital Market - Live News